Results 161 to 170 of about 179,948 (273)
Comparison of Different Treatment Protocols in Postmenopausal Osteoporosis
This study was planned to compare the effects of three different treatment protocols including calcitonin, calcium and Vit D on bone mineral density (BMD) of postmenauposal women.
Zühal E. Altay +4 more
core
Osteoporosis Awareness and Knowledge in Postmenopausal Breast Cancer Survivors
Objective: To determine the awareness and knowledge levels of osteoporosis in postmenopausal breast cancer survivors (PBCS) who have completed adjuvant chemoradiotherapy, are under hormonal therapy, or are being monitored, and to examine potentially ...
Lale Aktekin +4 more
core +1 more source
The Associations of Diabetes Mellitus and Obesity on Osteoporosis
ABSTRACT Objectives Osteoporosis is a common and debilitating condition that disproportionately affects older adults, particularly women, leading to increased fracture risk and reduced quality of life. While traditional risk factors such as age, hormonal changes, and lifestyle factors are well established, the impacts of diabetes and obesity on ...
Mendon G. Thomas +1 more
wiley +1 more source
Postmenopausal Osteoporosis, Endothelial Dysfunction, and Cardiovascular Risk. [PDF]
Pickering ME +11 more
europepmc +1 more source
ABSTRACT Objective The menopausal transition remains a neglected area of women's health in sub‐Saharan Africa, often framed as a private, non‐medical life stage. This study investigates how cultural stigma, norms of silence and healthcare‐system factors shape professional healthcare‐seeking for menopause‐related symptoms among perimenopausal women ...
Ukie Seimokumo Angaye +1 more
wiley +1 more source
Bisphosphonates are currently the most preferred class of drugs used for the treatment of metabolic bone disease such as osteoporosis and Paget’s disease. Although their exact mechanism has not been identified, the compounds containing amino group (amino
Çiğdem Tüzün +2 more
core
Propensity score‐matched comparison of 23 SGLT2 inhibitor users and 23 non‐users revealed that SGLT2 inhibitor use was associated with significantly lower Neuropilin‐1 (NRP1) levels (74.25 vs. 87.61 ng/mL; p = 0.015) and a higher Sema3A/NRP1 ratio (0.14 vs.
Sertas Erarslan, Burcu Cosgun Bora
wiley +1 more source
Evidence mapping and meta-analysis of traditional Chinese medicine for postmenopausal osteoporosis. [PDF]
Xi X, Yan X, Fan J, Zhang Y, Wang Z.
europepmc +1 more source
The aging of the human body is a complex process driven by multiple contributing factors. Based on their underlying mechanisms, current anti‐aging interventions can be classified into six primary categories. This paper summarizes the most promising anti‐aging strategies within each class. ABSTRACT The global prevalence of aging and age‐related diseases
Feifei Li +4 more
wiley +1 more source
The estrogen-ferroptosis axis in postmenopausal osteoporosis, osteoarthritis, and intervertebral disc degeneration: shared mechanisms and emerging evidence. [PDF]
Zheng K +6 more
europepmc +1 more source

